Analystreport

Five Prime Therapeutics Inc (NASDAQ: FPRX) is now covered by analysts at Wedbush. They set a "neutral" rating on the stock.

FIVE PRIME THERAPEUTICS  (FPRX) 
Last five prime therapeutics earnings: 2/27 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.fiveprime.com/investor-relations